Tenaya Therapeutics Inc - ESG Rating & Company Profile powered by AI
If you work at Tenaya Therapeutics Inc and you wish to licence your ESG rating, please get in touch. Jump to the bottom of this page for potential risks for Tenaya Therapeutics Inc based on sector, geography and marketcap. This analysis of Tenaya Therapeutics Inc employs data points from across the web as well as from available disclosures by Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 8.0; made up of an environmental score of 8.0, social score of 8.0 and governance score of 8.0.
8.0
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 36 | Repligen Corp | 8.1 | High |
| 36 | Zealand Pharma A/S | 8.1 | High |
| 55 | Tenaya Therapeutics Inc | 8.0 | High |
| 55 | Abbott India Ltd | 8.0 | High |
| 55 | Amrutanjan Health Care Ltd | 8.0 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Tenaya Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Tenaya Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Tenaya Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Tenaya Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Tenaya Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Tenaya Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Tenaya Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Tenaya Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Tenaya Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Tenaya Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Tenaya Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Tenaya Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Tenaya Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Tenaya Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Tenaya Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Tenaya Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Tenaya Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Tenaya Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hypertrophic cardiomyopathy (gHCM) caused by haploinsufficient myosin binding protein C3 (MYBPC3) gene mutations; and TN-301, a small molecule inhibitor of histone deacetylase 6 (HDAC6i) for use in heart failure with preserved ejection fraction (HFpEF) and genetic dilated cardiomyopathy (gDCM). It is also developing TN-401, an AAV-based gene therapy that addresses genetic arrhythmogenic right ventricular cardiomyopathy (gARVC) caused by plakophilin 2 (PKP2) gene mutations; an AAV-based gene therapy designed to deliver the dwarf open reading frame (DWORF) gene in the heart for DCM; and Reprogramming program, an AAV-based approach for cardiac regeneration to replace heart cells lost in patients experiencing heart failure due to prior myocardial infarction. The company was incorporated in 2016 and is headquartered in South San Francisco, California.